Pages that link to "Q30411367"
Jump to navigation
Jump to search
The following pages link to Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome (Q30411367):
Displayed 25 items.
- Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). (Q26739860) (← links)
- Current understanding in source control management in septic shock patients: a review (Q28071599) (← links)
- Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections? (Q30278641) (← links)
- Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference (Q33640559) (← links)
- Early Liver Dysfunction in Patients With Intra-Abdominal Infections (Q36206891) (← links)
- Sepsis Patients with First and Second-Hit Infections Show Different Outcomes Depending on the Causative Organism (Q36620689) (← links)
- Bloodstream infections in the Intensive Care Unit (Q36913336) (← links)
- Bedside dressing changes for open abdomen in the intensive care unit is safe and time and staff efficient (Q36945248) (← links)
- Basis for selecting optimum antibiotic regimens for secondary peritonitis (Q38633450) (← links)
- Unmet needs in the management of intra-abdominal infections (Q40079705) (← links)
- Therapeutic management of peritonitis: a comprehensive guide for intensivists (Q40752468) (← links)
- Mortality risk factor analysis in colonic perforation: would retroperitoneal contamination increase mortality in colonic perforation? (Q47099398) (← links)
- Immediate interruption of sedation compared with usual sedation care in critically ill postoperative patients (SOS-Ventilation): a randomised, parallel-group clinical trial (Q47249753) (← links)
- Circulating stem cells, HIF-1, and SDF-1 in septic abdominal surgical patients: randomized controlled study protocol. (Q52660164) (← links)
- Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. (Q53706279) (← links)
- What every intensivist should know about the management of peritonitis in the intensive care unit. (Q55091146) (← links)
- Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections (Q59329994) (← links)
- Current Perspectives on Treatment of Gram-Positive Infections in India: What Is the Way Forward? (Q64069079) (← links)
- Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial (Q64070177) (← links)
- Trauma ICU Prevalence Project: the diversity of surgical critical care (Q64246775) (← links)
- Identification of Specific Components of the Eicosanoid Biosynthetic and Signaling Pathway Involved in Pathological Inflammation during Intra-abdominal Infection with Candida albicans and Staphylococcus aureus (Q88595312) (← links)
- Factors associated with outcomes of septic shock patients receiving high dose noradrenaline according to three primary infection sites (Q90145288) (← links)
- Clinical and Microbiological Characteristics of Patients with Complicated Intra-abdominal Infections in Intensive Care Unit (Q90289002) (← links)
- Antimicrobial Susceptibility of Microorganisms Isolated from Patients with Intraabdominal Infection in Korea: a Multicenter Study (Q91748111) (← links)
- Antimicrobial susceptibility changes of Escherichia coli and Klebsiella pneumoniae intra-abdominal infection isolate-derived pathogens from Chinese intra-abdominal infections from 2011 to 2015 (Q93185272) (← links)